Clinical Trials Directory

Trials / Completed

CompletedNCT02721992

Graves' Orbitopathy and Hypercholesterolemia

A Prospective Study on the Association Between Graves' Orbitopathy and Hypercholesterolemia

Status
Completed
Phase
Study type
Observational
Enrollment
250 (actual)
Sponsor
University of Pisa · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The investigators have recently observed retrospectively that the occurrence of Graves' Orbitopathy in patients with Graves' disease is less frequent in patients with normal cholesterol levels, in line with another recent observation suggesting that statins play a protective role in Graves' patients from developing Graves' Orbitopathy. The present study is designed in order to investigate the possible association between Graves' Orbitopathy and high cholesterol level as well as the relation between Graves' Orbitopathy degree and high cholesterol level

Conditions

Interventions

TypeNameDescription
OTHERNo interventionNo intervention

Timeline

Start date
2016-01-01
Primary completion
2017-06-01
Completion
2017-06-01
First posted
2016-03-29
Last updated
2017-08-14

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02721992. Inclusion in this directory is not an endorsement.

Graves' Orbitopathy and Hypercholesterolemia (NCT02721992) · Clinical Trials Directory